Becker, T., Hulsmann, S., Knudsen, H. C., et al (2002) Provision of services for people with schizophrenia in five European regions. Social Psychiatry and Psychiatric Epidemiology, 37, 465–474.
Breen, R. & Thornhill, J. T. (1998) Noncompliance with medication for psychiatric disorders. Reasons and remedies. CNS Drugs, 9, 457–471.
Chisholm, D. & Knapp, M. (2002) The economics of schizophrenia care in Europe: the EPSILON study. Epidemiologia e Psichiatrica Sociale, 11, 12–17.
Cummings, K. M., Kirscht, J. P., Becker, M. H., et al (1984) Construct validity comparisons of three methods for measuring patient compliance. Health Services Research, 19, 103–116.
David, A. S. (1990) Insight and psychosis. British Journal of Psychiatry, 156, 798–808.
Gray, R., Wykes, T., Edmonds, M., et al (2004) Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. British Journal of Psychiatry, 185, 157–162.
Kemp, R., David, A. & Hayward, P. (1996) Compliance therapy: an intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy, 24, 331–350.
Kemp, R., Kirov, G., Everitt, B., et al (1998) Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry, 172, 413–419.
Lacro, J. P., Dunn, L. B., Dolder, C. R., et al (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry, 63, 892–909.
Lukoff, D., Liberman, R. P. & Neuchterlein, K. H. (1986) Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophrenia Bulletin, 12, 578–602.
Matsui, D., Hermann, C., Klein, J., et al (1994) Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. Journal of Clinical Pharmacology, 34, 944–949.
Meijer, C. J., Schene, A. H. & Koeter, M. W. J. (2002) Quality of life in schizophrenia measured by the MOS SF–36 and the Lancashire Quality of Life Profile: acomparison. Acta Psychiatrica Scandinavica, 105, 293–300.
Mickey, R. M., Dunn, O. J. & Clark, V. A. (2004) Applied Statistics: Analysis of Variance and Regression
New York: John Wiley.
Morisky, D. E., Green, L. W. & Levine, D. M. (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24, 67–74.
Nose, M., Barbui, C. & Tansella, M. (2003a) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine, 33, 1149–1160.
Nose, M., Barbui, C., Gray, R., et al (2003b) Clinical interventions for treatment non-adherence in psychosis: meta-analysis. British Journal of Psychiatry, 183, 197–206.
O'Donnell, C., Donohoe, G., Sharkey, L., et al (2003) Compliance therapy: a randomised controlled trial in schizophrenia. BMJ, 327, 834.
Robinson, D., Woerner, M. G., Alvir, J. M., et al (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241–247.
Rood, M. J., Borggreve, S. E. & Huizinga, T. W. (2000) Sensitivity to change of the MOS SF–36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy. Journal of Rheumatology, 27, 2057–2059.
Roth, A. & Fonagy, P. (1996) What Works for Whom? A Critical Review of Psychotherapy Research. New York: Guilford Press.
Russo, J., Trujillo, C. A., Wingerson, D., et al (1998) The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients. Medical Care, 36, 752–756.
Tunis, S. L., Croghan, T. W., Heilman, D. K., et al (1999) Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF–36) in schizophrenic patients treated with olanzapine versus haloperidol. Medical Care, 37, 678–691.
Tunis, S. R., Stryer, D. B. & Clancy, C. M. (2003) Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Assocation, 290, 1624–1632.
Vallis, T. M., Shaw, B. F. & Donson, K. S. (1986) The cognitive therapy scale: psychometric properties. Journal of Consulting and Clinical Psychology, 54, 381–385.
Ventura, J., Green, M., Schaner, A., et al (1993) Training and quality assurance with the Brief Psychiatric Rating Scale. The ‘drift busters'. International Journal of Methods in Psychiatric Research, 3, 221–244.
Ware, J. & Sherbourn, C. (1992) The MOS, 36 item Short-Form Health Survey (SF–36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.
Ware, J. E. & Kosinski, M. (2003a) Physical and Mental Health Summary Scales. A Manual for Users of Version 1, 2nd edn.
Lincoln, RI: Quality Metric.
Ware, J. E. & Kosinski, M. (2003b) SF-36 Physical and Mental Health Summary Scales. A Manual for Users of Version 1, 2nd edn.
Lincoln, RI: Quality Metric.
White, I. & Thompson, S. (2005) Adjusting for partially missing baseline measurements in randomised trials. Statistics in Medicine, 24, 993–1007.
Wing, J. K., Babor, T., Brugha, T., et al (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry
Archives of General Psychiatry, 47, 589–593.
World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10). Geneva: WHO.
World Health Organization (2003) Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO.
Zygmunt, A., Olfson, M., Boyer, C. A., et al (2002) Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159, 1653–1664.